Cargando…
MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer
BACKGROUND: Altered microRNAs expression mediates tumor development and progression in many type cancers including triple negative breast cancer (TNBC). Here we detected the effect of miR-454 on cell proliferation, migration and invasion of triple negative breast cancer cells. RESULTS: miR-454 promo...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541748/ https://www.ncbi.nlm.nih.gov/pubmed/28795052 http://dx.doi.org/10.1186/s40709-017-0067-x |
_version_ | 1783254873379176448 |
---|---|
author | Li, Qun Liu, Jia Meng, Xianying Pang, Renzhu Li, Jie |
author_facet | Li, Qun Liu, Jia Meng, Xianying Pang, Renzhu Li, Jie |
author_sort | Li, Qun |
collection | PubMed |
description | BACKGROUND: Altered microRNAs expression mediates tumor development and progression in many type cancers including triple negative breast cancer (TNBC). Here we detected the effect of miR-454 on cell proliferation, migration and invasion of triple negative breast cancer cells. RESULTS: miR-454 promoted the proliferation of TNBC, and enhanced migration and invasion in TNBC cells. Meanwhile, miR-454 improved the survival of TNBC cells after ironizing radiation. miR-454 inhibited radiation-induced apoptosis in TNBC cells by regulation of caspase 3/7 and Bcl-2 expression. Furthermore, PTEN and pAKT levels in TNBC cells were changed after overexpression of miR-454. CONCLUSIONS: miR-454 played an essential role in tumor development and progression in TNBC, and might be used as a potential biomarker to predict radiotherapy response and prognosis in TNBC. |
format | Online Article Text |
id | pubmed-5541748 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55417482017-08-09 MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer Li, Qun Liu, Jia Meng, Xianying Pang, Renzhu Li, Jie J Biol Res (Thessalon) Research BACKGROUND: Altered microRNAs expression mediates tumor development and progression in many type cancers including triple negative breast cancer (TNBC). Here we detected the effect of miR-454 on cell proliferation, migration and invasion of triple negative breast cancer cells. RESULTS: miR-454 promoted the proliferation of TNBC, and enhanced migration and invasion in TNBC cells. Meanwhile, miR-454 improved the survival of TNBC cells after ironizing radiation. miR-454 inhibited radiation-induced apoptosis in TNBC cells by regulation of caspase 3/7 and Bcl-2 expression. Furthermore, PTEN and pAKT levels in TNBC cells were changed after overexpression of miR-454. CONCLUSIONS: miR-454 played an essential role in tumor development and progression in TNBC, and might be used as a potential biomarker to predict radiotherapy response and prognosis in TNBC. BioMed Central 2017-08-03 /pmc/articles/PMC5541748/ /pubmed/28795052 http://dx.doi.org/10.1186/s40709-017-0067-x Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Li, Qun Liu, Jia Meng, Xianying Pang, Renzhu Li, Jie MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer |
title | MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer |
title_full | MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer |
title_fullStr | MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer |
title_full_unstemmed | MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer |
title_short | MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer |
title_sort | microrna-454 may function as an oncogene via targeting akt in triple negative breast cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541748/ https://www.ncbi.nlm.nih.gov/pubmed/28795052 http://dx.doi.org/10.1186/s40709-017-0067-x |
work_keys_str_mv | AT liqun microrna454mayfunctionasanoncogeneviatargetingaktintriplenegativebreastcancer AT liujia microrna454mayfunctionasanoncogeneviatargetingaktintriplenegativebreastcancer AT mengxianying microrna454mayfunctionasanoncogeneviatargetingaktintriplenegativebreastcancer AT pangrenzhu microrna454mayfunctionasanoncogeneviatargetingaktintriplenegativebreastcancer AT lijie microrna454mayfunctionasanoncogeneviatargetingaktintriplenegativebreastcancer |